Gary E Clapp

Title: Innovations of Gary E Clapp

Introduction

Gary E Clapp is a notable inventor based in Lawrence, Kansas, who has made significant contributions to the field of pharmaceuticals. With a total of six patents to his name, Clapp's work focuses on the development of innovative compositions that enhance the efficacy of taxane particles.

Latest Patents

Among his latest patents, Clapp has developed compositions that include at least 95% by weight of a taxane or a pharmaceutically acceptable salt thereof. These particles are characterized by a mean bulk density ranging from about 0.050 g/cm to about 0.15 g/cm, and a specific surface area (SSA) of at least 18 m/g, with options extending up to 35 m/g. The methods for making and utilizing these compositions are also detailed in his patents, showcasing his commitment to advancing pharmaceutical technology.

Career Highlights

Clapp's career is marked by his role at Crititech, Inc., where he has been instrumental in driving research and development efforts. His innovative approach has led to the creation of valuable pharmaceutical compositions that have the potential to improve patient outcomes.

Collaborations

Clapp has collaborated with talented individuals such as Jahna Espinosa and Michael Baltezor, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Gary E Clapp's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to advancing medical science. His work continues to pave the way for new therapeutic solutions.